ATKR vs REGN · rev $2.85B vs P/E 14, rev $14.34B
Atkore International Group Inc (ATKR) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Atkore International Group Inc (ATKR) is a electrical equipment & parts company listed on NYSE.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported ATKR revenue for 2025-09-30 was $2.85B. Net income was -$15.2M. ATKR currently screens at market cap $2.69B.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
ATKR currently screens at market cap $2.69B. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the ATKR and REGN stock pages for the full models.
Not investment advice.